Glucagon-Like Peptide-1 Receptor Agonist Cases Reported to United States Poison Centers, 2017–2022

Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of medications for management of diabetes and obesity. The objective of this study is to characterize the epidemiology of GLP-1RA cases reported to US poison centers. Methods We analyzed cases involving a GLP-1RA reported...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical toxicology 2024-04, Vol.20 (2), p.193-204
Hauptverfasser:	Gaw, Christopher E., Hays, Hannah L., Kemp, Cydney A., Kistamgari, Sandhya, Spiller, Henry A., Rine, Natalie I., Rhodes, Allison L., Zhu, Motao, Smith, Gary A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Agonists Biomedical and Life Sciences Biomedicine Critical care Data systems Diabetes mellitus Diabetes Mellitus, Type 2 - drug therapy Epidemiology Female GLP-1 receptor agonists Glucagon Glucagon-like peptide 1 Glucagon-Like Peptide-1 Receptor Agonists Health care Health care facilities Health facilities Health services Humans Hypoglycemic Agents - therapeutic use Liraglutide - therapeutic use Liraglutide - toxicity Medical treatment Original Original Article Peptides Pharmacology/Toxicology Poisons Poisons - therapeutic use Receptors United States - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!